Ferring Pharmaceuticals Private Limited

Ferring Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U74140MH1997FTC109220 Incorporated 04 July 1997 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Foreign Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹233.5 Cr
▲ 7% YoY
Net profit · FY 2024
₹20.57 Cr
Net margin 8.8%
EBITDA · FY 2024
₹31.19 Cr
EBITDA margin 13.4%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹1.26 Cr
Issued & subscribed
Open charges
₹1.2 Cr
Secured borrowings
Company age
29 yrs
Est. 1997
Employees · EPFO
168
Provident fund records

About Ferring Pharmaceuticals Private Limited

Data last updated:

Ferring Pharmaceuticals Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Ferring B.V. (Netherlands). It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 July 1997 and has been in existence for over 29 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74140MH1997FTC109220. Its GSTIN is 27AAACF3120H1Z4 (Maharashtra). The company holds 13 GST registrations, of which 10 are active.

The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹1.26 Cr. It is led by directors Abhilash Mishra and Bhuvan Pratap Motta.

Its last annual general meeting (AGM) was held on 22 August 2025, and its latest financial statements are for the year ended 31 December 2024. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2024, the company reported a revenue of ₹233.5 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹20.57 Cr (net margin 8.8%) and EBITDA of ₹31.19 Cr (EBITDA margin 13.4%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 8% over five years.

The company has about 168 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Ferring Pharmaceuticals. As per MCA filings, the company has open charges of ₹1.2 Cr on record. Court records list 22 cases involving the company, including 14 filed by the company and 8 filed against it; 5 cases are pending. The company has 1 deal on record (1 funding round), with disclosed funding of ₹19.25 Cr; the latest was in September 2013. The company has 4 MSME Form 1 returns on record between 2016 and 2019, listing 62 overdue payments to 21 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ferring.com.

Company details

CIN U74140MH1997FTC109220
Registration Number 109220
Incorporation Date 04 July 1997
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 22 August 2025
Date of Balance Sheet 31 December 2024
Parent Company Ferring B.V. (Netherlands)
Compliance Status Active Compliant

CIN history

Ferring Pharmaceuticals has one previous CIN (Corporate Identification Number): U74140MH1997PTC109220. The current CIN is U74140MH1997FTC109220, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U74140MH1997FTC109220Current
U74140MH1997PTC109220Previous

Contact details

Ferring Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is ferring.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    509 & 510 A – Wing 5th Floor The Capital Plot No. C – 70 Block G Bandra Kurla Com, Plex, Mumbai, Maharashtra, India – 400051
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Ferring Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Ferring Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Ferring Pharmaceuticals operates one associated brand: Ferring Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Provider of drugs in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedicsferring.com

Financials of Ferring Pharmaceuticals Private Limited

FY 2024 filings available

Ferring Pharmaceuticals Private Limited reported revenue of ₹233.5 Cr (up 7% YoY) for FY 2024.

Revenue · FY 2024
₹233.5 Cr ▲ 7%
Net profit · FY 2024
₹20.57 Cr margin 8.8%
EBITDA · FY 2024
₹31.19 Cr margin 13.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 12%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▼ 41%
3 years · compounded
▲ 14%
5 years · compounded
▲ 28%

Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 7% growth in the latest year. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹31.19 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹20.57 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin13.4%
Net Profit Margin8.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ferring Pharmaceuticals Private Limited, buy the company report.

Board of directors of Ferring Pharmaceuticals Private Limited

Ferring Pharmaceuticals has 2 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Abhilash MishraAdditional Director26 Nov 20250 Years 11 MonthsCurrent
Bhuvan Pratap MottaAdditional Director28 Nov 20250 Years 10 MonthsCurrent

Auditor

Ferring Pharmaceuticals Private Limited is audited by DELOITTE HASKINS & SELLS LLP for the financial year 2022.

Auditor firmFinancial yearFirm registration number
DELOITTE HASKINS & SELLS LLPFY 2022117366W

Shareholding

The shareholding of Ferring Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Ferring Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.2 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹1.00 Cr
The Hongkong and Shanghai Banking Corporation Limited₹0.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Jan 2019100244956The Hongkong and Shanghai Banking Corporation Limited₹20 LakhOpen
26 Feb 200090147407State Bank of India₹1 CrOpen

Total charge records: 2 View all charges

Deals & funding

Ferring Pharmaceuticals Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹19.25 Cr; the latest was in September 2013.

Total deals
1
Funding round
1
Disclosed funding
₹19.25 Cr

Deals on record (1 of 1)

WhenDealAmountParties
Sep 2013Funding round₹19.25 CrInvestors: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Ferring Pharmaceuticals Private Limited has 4 MSME Form 1 returns on record between 2016 and 2019, listing 62 overdue payments to 21 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 21)

SupplierAmount dueDue sinceReported on
Dap E-Nnovative Solutions Private Limited
an individual supplier
Air Care Systems Private Limited
an individual supplier
Airmark Pen House

To see the full MSME payment records of Ferring Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Ferring Pharmaceuticals Private Limited has a workforce of 168 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.

Employee count
168
Active EPFO establishments
1

GST

Ferring Pharmaceuticals has 13 GST registrations: 10 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
13
Active
10
Cancelled / inactive
3
GSTINStateStatusRegistered on
27AAACF3120H1Z4MaharashtraActive01 Jul 2017
03AAACF3120H1ZEPunjabActive01 Jul 2017
08AAACF3120H1Z4RajasthanActive01 Jul 2017
09AAACF3120H1Z2Uttar PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Ferring Pharmaceuticals Private Limited, buy the company report.

Recent activity

Ferring Pharmaceuticals Private Limited has 15 board changes on record since 2013: 4 appointments and 11 cessations. The latest: Bhuvan Pratap Motta was appointed as Additional Director on 28 Nov 2025.

Appointed
Bhuvan Pratap Motta was appointed as Additional Director.
Appointed
Abhilash Mishra was appointed as Additional Director.
AGM
Ferring Pharmaceuticals Private Limited last Annual general meeting of members was held on 22 Aug 2025 as per latest MCA records.
Ceased
Anindya Ghosh ceased to be Additional Director.
Filing
Ferring Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Dec 2024 with Roc Mumbai I.
Ceased
Armin Udo Metzger ceased to be Director.
Ceased
Didier Page ceased to be Additional Director.
Ceased
Sudheendra Rangrao Kulkarni ceased to be Director.
Appointed
Sudheendra Rangrao Kulkarni was appointed as Managing Director.
Appointed
Didier Page was appointed as Director.
Ceased
Abhilash Mishra ceased to be Additional Director.
Ceased
Suresh Pattathil ceased to be Managing Director.

8 earlier events are in the company report.

Frequently asked questions

Ferring Pharmaceuticals is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 July 1997 (29+ years old) and is registered under CIN U74140MH1997FTC109220.

Ferring Pharmaceuticals has 2 current directors:

The latest financial statements of Ferring Pharmaceuticals on record with the MCA are for the year ended 31 December 2024. Its last annual general meeting was held on 22 August 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Ferring Pharmaceuticals is 27AAACF3120H1Z4, registered in Maharashtra. The company has 13 GST registrations in all, of which 10 are active and 3 are cancelled or inactive. Other active GSTINs include 03AAACF3120H1ZE (Punjab), 08AAACF3120H1Z4 (Rajasthan), 09AAACF3120H1Z2 (Uttar Pradesh).

The CIN (Corporate Identification Number) of Ferring Pharmaceuticals is U74140MH1997FTC109220. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ferring Pharmaceuticals has 22 court cases on record: 14 filed by the company and 8 filed against it. 5 are pending. Most are in the high courts.

Ferring Pharmaceuticals was incorporated on 04 July 1997, making it 29+ years old. It is registered with the Registrar of Companies, Mumbai.

Ferring Pharmaceuticals has 1 deal on record (1 funding round), with disclosed funding of ₹19.25 Cr; the latest was in September 2013.

Bhuvan Pratap Motta was appointed as Additional Director on 28 Nov 2025. Abhilash Mishra was appointed as Additional Director on 26 Nov 2025. Anindya Ghosh ceased to be Additional Director on 01 Jul 2025. Ferring Pharmaceuticals has 15 board changes on record in total.

Ferring Pharmaceuticals has 4 MSME Form 1 returns on record between 2016 and 2019, listing 62 overdue payments to 21 micro and small suppliers. The latest return was filed on 25 Dec 2019.

Ferring Pharmaceuticals can be reached through the website ferring.com. Its registered office is in Mumbai, Maharashtra, India.